Data
Genomics
Solutions
Research
Resources
About
- Blog
- Members
- Leadership
- Events & webinars
- News
- Careers



Sign in

Close

Blog

Truveta AI quality for real world data

How Truveta benchmarks AI model quality for clinical concept extraction

Abiomed Impella device cardiovascular research heart failure patient outcomes

Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures

Wegovy use among US teens up 50% as obesity crisis worsens

measles outbreak Texas CDC recommendation early vaccination MMR MMRV EHR data RWD RWE

Evaluating recent trends in early measles vaccinations in Texas

Truveta banner featuring the phrase 'Cancer innovation needs better data — not just better drugs' alongside an illustrated icon of a cancer cell. The banner highlights '7M cancer patient journeys' and '100+ cancer types' under the theme of 'Regulatory-grade data'

Cancer innovation needs better data—not just better drugs

Truveta Research GLP-1 use overweight obesity cardiovascular disease semaglutide Wegovy tirzepatide Zepbound liraglutide

ISPOR 2025: Trends in the prescribing and dispensing of GLP-1 anti-obesity medications among adults with cardiovascular disease

Truveta Research stopping GLP-1 medications Ozempic Wegovy Mounjaro Zepbound reasons for discontinuation

ISPOR 2025: Real-world temporal and indication-specific variation in drivers of GLP-1 RA discontinuation

HIV cabotegravir use RWD RWE Truveta Research

ISPOR 2025: Characteristics and adherence of patients initiating injectable cabotegravir for HIV treatment or prevention

« Previous
1
…
13
14
15
…
43
Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Genome Project

© Truveta 2026

Our website uses cookies to ensure you have the best experience.